Vivani Medical, Inc. (VANI)Healthcare | Biotechnology | Alameda, United States | NasdaqCM
1.51 USD
+0.17
(12.687%)
⇧
(April 20, 2026, 4 p.m.
EDT)
Short-term: ★★☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:08 p.m. EDT
Despite the recent 4-week earnings rally and significant insider accumulation, VANI is a cash-burning biotech binary play with no fundamental value (negative earnings, high debt/equity) and zero seasonal interest. The only 'buy' thesis is a belief in the semaglutide implant data; otherwise, it is a high-risk speculation where the lack of analyst attention and options volume precludes any reliable technical setup. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.137746 |
| AutoARIMA | 0.160815 |
| AutoETS | 0.161149 |
| MSTL | 0.174696 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 45% |
| H-stat | 7.41 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.807 |
| Excess Kurtosis | 0.26 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 119.866 |
| Market Cap | 127,818,176 |
| Forward P/E | -4.31 |
| Beta | 3.37 |
| Previous Name | Second Sight Medical Products, Inc. |
| Website | https://www.vivani.com |
As of April 18, 2026, 11:08 p.m. EDT: Options data reveals a complex divergence in sentiment. The April 17 expiry shows massive put volume (1.5k vol) relative to Open Interest (482), indicating active selling or hedging pressure despite the short OTM nature relative to the $1.34 price. In contrast, the May and August expirations feature strong Call Open Interest (OI), particularly at the $2.00 strike in August, suggesting speculative positioning for a recovery to $2.00 over the next 6-9 months. However, general Open Interest is low and insignificant, indicating that the recent price run-up is driven purely by physical share flow (insider buying) rather than institutional or retail options speculation.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.4803921 |
| Address1 | 1,350 South Loop Road |
| All Time High | 576.48 |
| All Time Low | 0.754 |
| Ask | 1.55 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 373,850 |
| Average Daily Volume3 Month | 326,014 |
| Average Volume | 326,014 |
| Average Volume10Days | 373,850 |
| Beta | 3.367 |
| Bid | 1.47 |
| Bid Size | 1 |
| Book Value | 0.206 |
| City | Alameda |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.51 |
| Current Ratio | 2.711 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.53 |
| Day Low | 1.27 |
| Debt To Equity | 119.866 |
| Display Name | Vivani Medical |
| Dividend Date | 1,578,268,800 |
| Earnings Timestamp | 1,774,555,200 |
| Earnings Timestamp End | 1,778,702,400 |
| Earnings Timestamp Start | 1,778,702,400 |
| Ebitda | -27,132,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -4.808 |
| Enterprise Value | 130,441,184 |
| Eps Current Year | -0.35 |
| Eps Forward | -0.35 |
| Eps Trailing Twelve Months | -0.43 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.17256 |
| Fifty Day Average Change | 0.33744 |
| Fifty Day Average Change Percent | 0.2877806 |
| Fifty Two Week Change Percent | 48.03921 |
| Fifty Two Week High | 1.92 |
| Fifty Two Week High Change | -0.40999997 |
| Fifty Two Week High Change Percent | -0.21354166 |
| Fifty Two Week Low | 0.923 |
| Fifty Two Week Low Change | 0.587 |
| Fifty Two Week Low Change Percent | 0.6359697 |
| Fifty Two Week Range | 0.923 - 1.92 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,416,407,400,000 |
| Float Shares | 38,860,113 |
| Forward Eps | -0.35 |
| Forward P E | -4.3142858 |
| Free Cashflow | -15,893,500 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 42 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.34344003 |
| Held Percent Institutions | 0.064229995 |
| Implied Shares Outstanding | 84,647,803 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,660,867,200 |
| Last Split Factor | 1:3 |
| Long Business Summary | Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in clinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature and subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant for metabolic diseases in cats. The company is headquartered in Alameda, California. |
| Long Name | Vivani Medical, Inc. |
| Market | us_market |
| Market Cap | 127,818,176 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_260862802 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-20 |
| Net Income To Common | -26,609,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 127,818,182 |
| Number Of Analyst Opinions | 3 |
| Open | 1.31 |
| Operating Cashflow | -24,320,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 415 506 8462 |
| Pre Market Change | 0.00999999 |
| Pre Market Change Percent | 0.66225106 |
| Pre Market Price | 1.52 |
| Pre Market Time | 1,776,774,833 |
| Prev Name | Second Sight Medical Products, Inc. |
| Previous Close | 1.34 |
| Price Eps Current Year | -4.3142858 |
| Price Hint | 4 |
| Price To Book | 7.330097 |
| Profit Margins | 0.0 |
| Quick Ratio | 2.558 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.17 |
| Regular Market Change Percent | 12.6866 |
| Regular Market Day High | 1.53 |
| Regular Market Day Low | 1.27 |
| Regular Market Day Range | 1.27 - 1.53 |
| Regular Market Open | 1.31 |
| Regular Market Previous Close | 1.34 |
| Regular Market Price | 1.51 |
| Regular Market Time | 1,776,715,200 |
| Regular Market Volume | 921,688 |
| Return On Assets | -0.42549 |
| Return On Equity | -1.5962199 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 84,647,803 |
| Shares Percent Shares Out | 0.0063 |
| Shares Short | 532,131 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 290,597 |
| Short Name | Vivani Medical, Inc. |
| Short Percent Of Float | 0.0087 |
| Short Ratio | 2.28 |
| Source Interval | 15 |
| State | CA |
| Symbol | VANI |
| Target High Price | 7.0 |
| Target Low Price | 3.5 |
| Target Mean Price | 4.83333 |
| Target Median Price | 4.0 |
| Total Cash | 16,232,000 |
| Total Cash Per Share | 0.192 |
| Total Debt | 18,855,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.43 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.338815 |
| Two Hundred Day Average Change | 0.17118502 |
| Two Hundred Day Average Change Percent | 0.1278631 |
| Type Disp | Equity |
| Volume | 921,688 |
| Website | https://www.vivani.com |
| Zip | 94,502 |